C277R (p.Cys277Arg) variant of TP53 (Cellular tumor antigen p53)
C277R (p.Cys277Arg) in TP53 (Cellular tumor antigen p53) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Li-Fraumeni syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.85 / 1. The record also includes population frequency data, published literature, and structural context.
C277R (p.Cys277Arg) variant details
- p.Cys277Arg
- rs1064795369
- ClinGen CA16620617
- cosmic curated COSV53188
- ClinVar RCV000480494
- Uncertain significance
- Li-Fraumeni syndrome
- Missense
- Variant Prioritization Score for Impact Estimate 0.854
- REVEL 0.89
- ESM-1b 1.00
- AlphaMissense 1.00
- MetaLR 0.99
- MetaSVM 1.07
- CADD 31.00
- ClinVar: Uncertain significance (Li-Fraumeni syndrome)
- EBI: Likely pathogenic (in sporadic cancers)
- UniProt: Likely pathogenic (in sporadic cancers)
- Most common in the East Asian population (allele frequency 0.0015)
- Structural context available
- Cited in: Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. (PMID 15604628)
- Cited in: Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National… (PMID 17508274)